These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

926 related items for PubMed ID: 18802001

  • 1. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease.
    Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, Staufenbiel M, Konnerth A, Garaschuk O.
    Science; 2008 Sep 19; 321(5896):1686-9. PubMed ID: 18802001
    [Abstract] [Full Text] [Related]

  • 2. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease.
    Chen G, Chen KS, Knox J, Inglis J, Bernard A, Martin SJ, Justice A, McConlogue L, Games D, Freedman SB, Morris RG.
    Nature; 2008 Sep 19; 408(6815):975-9. PubMed ID: 11140684
    [Abstract] [Full Text] [Related]

  • 3. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
    Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW.
    Nature; 2008 Sep 19; 408(6815):982-5. PubMed ID: 11140686
    [Abstract] [Full Text] [Related]

  • 4. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E, Kurunczi A, Kasza A, Horváth J, Felszeghy K, Laroche S, Toldi J, Párducz A, Penke B, Penke Z.
    Neuroscience; 2007 Jun 15; 147(1):28-36. PubMed ID: 17499931
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.
    Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, St George-Hyslop P, Westaway D.
    Nature; 2007 Jun 15; 408(6815):979-82. PubMed ID: 11140685
    [Abstract] [Full Text] [Related]

  • 7. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
    Klausner AP, Sharma S, Fletcher S, Neff P, Yang SK, Son H, Tuttle JB, Steers WD.
    J Urol; 2008 Mar 15; 179(3):1173-7. PubMed ID: 18206173
    [Abstract] [Full Text] [Related]

  • 8. Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency.
    Stoltenberg M, Bush AI, Bach G, Smidt K, Larsen A, Rungby J, Lund S, Doering P, Danscher G.
    Neuroscience; 2007 Dec 05; 150(2):357-69. PubMed ID: 17949919
    [Abstract] [Full Text] [Related]

  • 9. Absence of synaptophysin near cortical neurons containing oligomer Abeta in Alzheimer's disease brain.
    Ishibashi K, Tomiyama T, Nishitsuji K, Hara M, Mori H.
    J Neurosci Res; 2006 Aug 15; 84(3):632-6. PubMed ID: 16721760
    [Abstract] [Full Text] [Related]

  • 10. Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in transgenic mice.
    Bernardo A, Harrison FE, McCord M, Zhao J, Bruchey A, Davies SS, Jackson Roberts L, Mathews PM, Matsuoka Y, Ariga T, Yu RK, Thompson R, McDonald MP.
    Neurobiol Aging; 2009 Nov 15; 30(11):1777-91. PubMed ID: 18258340
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Decreased acetylcholine release is correlated to memory impairment in the Tg2576 transgenic mouse model of Alzheimer's disease.
    Watanabe T, Yamagata N, Takasaki K, Sano K, Hayakawa K, Katsurabayashi S, Egashira N, Mishima K, Iwasaki K, Fujiwara M.
    Brain Res; 2009 Jan 16; 1249():222-8. PubMed ID: 18996097
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease.
    Grutzendler J, Helmin K, Tsai J, Gan WB.
    Ann N Y Acad Sci; 2007 Feb 16; 1097():30-9. PubMed ID: 17413007
    [Abstract] [Full Text] [Related]

  • 18. Strain specific differences in memory and neuropathology in a mouse model of Alzheimer's disease.
    Glazner KA, Odero GL, Anema E, Motnenko A, Schapansky J, Grossman D, Oliver DR, Glazner GW, Albensi BC.
    Life Sci; 2010 Jun 19; 86(25-26):942-50. PubMed ID: 20470790
    [Abstract] [Full Text] [Related]

  • 19. [Brain lesions, pathogenic and etiologic hypotheses of Alzheimer's disease].
    Dessi F, Colle MA, Hauw JJ, Duyckaerts C.
    Rev Prat; 1998 Nov 01; 48(17):1873-8. PubMed ID: 9854388
    [Abstract] [Full Text] [Related]

  • 20. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury.
    Dickson TC, Chuckowree JA, Chuah MI, West AK, Vickers JC.
    Neurobiol Dis; 2005 Mar 01; 18(2):286-95. PubMed ID: 15686957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.